Memory Enhancement Drugs Market
- 2026 年市場規模
- USD 9,823.6 Mn
- 2033 年預估規模
- USD 14,252.5 Mn
- 年複合成長率 CAGR
- 5.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Memory Enhancement Drugs Market, By Drug Class (Cholinesterase Inhibitors, Smart Drugs and Cognitive Enhancers (Nootropics), Vitamins and Supplements, Others), By Route of Administration (Oral, Injectable, Topical), By Application (Disease treatment, Athletic performance, Academic performance, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Drugs that improve memory are used to treat people who have memory loss as a result of age or traumatic injury to the central nervous system (CNS). Alzheimer's disease may begin as a result of the onset of memory loss or a decline in cognition. Brain cells frequently die as a result of trauma, particularly to the brain, and although memory loss is normal as people age, it is treatable with medications that improve memory.
Despite the low market presence of regulatory authorities-approved memory-enhancing medications, several clinical trials are being conducted to examine the results. The majority of currently available medications that improve memory come from diet, such as vitamins, antioxidants, lipids, etc. Different countries of the world have also approved new medications that improve memory for medical use. Ritalin and Adderall are two examples of off-label medications that are being used as memory boosters. The goal of cognitive and memory enhancement medications and external supplements is to increase a person's cognitive capacity, which includes executive functions like motivation, creativity, and memory. These medications are prescribed to patients who have trouble sustaining their cognitive functions at their peak levels. These medications are used to treat patients with mental health conditions such Alzheimer's, schizophrenia, paranoia, and attention deficit disorder (ADD) in order to assist them cope with the ailment's symptoms.
Market Dynamics
Key players operating in the market are focused on increasing number of clinical trials for memory enhancement drugs. For instance, according to an article published in January 2020, on Journal of Biomed Science, researchers are currently testing a number of potential treatments with various targets, including anti-amyloid and anti-tau, neurotransmitter modification, anti-neuroinflammation and neuroprotection, cognitive enhancement, and treatments to relieve behavioral and psychological symptoms.
Key features of the study
• This report provides an in-depth analysis of the global memory enhancement drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global memory enhancement drugs market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
• Key companies covered as a part of this study Pfizer Inc., UCB S.A., Takeda Pharmaceutical Company, Shire plc. Sanochemia Pharmazeutika AG, Allergan plc., Novartis AG, Alkem Laboratories Ltd., Paradigm Healthcare, Intas Pharmaceutical Ltd., Taurus Laboratories Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global memory enhancement drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global memory enhancement drugs market.
Market Segmentation
• Global Memory Enhancement Drugs Market, By Drug Class
o Cholinesterase Inhibitors
o Smart Drugs and Cognitive Enhancers (Nootropics)
o Vitamins and Supplements
o Others
• Global Memory Enhancement Drugs Market, By Route of Administration
o Oral
o Injectable
o Topical
• Global Memory Enhancement Drugs Market, By Application
o Disease treatment
o Athletic performance
o Academic performance
o Others
• Global Memory Enhancement Drugs Market, By Distribution Channel
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• Global Memory Enhancement Drugs Market, By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players
o Pfizer Inc.
o UCB S.A.
o Takeda Pharmaceutical Company
o Shire plc.
o Sanochemia Pharmazeutika AG
o Allergan plc.
o Novartis AG
o Alkem Laboratories Ltd.
o Paradigm Healthcare
o Intas Pharmaceutical Ltd.
o Taurus Laboratories Pvt. Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Route of Administration
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Opportunity
o Impact Analysis
o Regulatory Scenario
o Market Trends
o Pipeline Analysis
o Key Developments
o Epidemiology
o PEST Analysis
4. Global Memory Enhancement Drugs Market, By Drug Class, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2030 (%)
Y-o-Y Growth Analysis, 2022 – 2030
Segment Trends
o Cholinesterase Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Smart Drugs and Cognitive Enhancers (Nootropics)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Vitamins and Supplements
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
5. Global Memory Enhancement Drugs Market, By Route of administration, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2030 (%)
Y-o-Y Growth Analysis, 2022 – 2030
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
6. Global Memory Enhancement Drugs Market, By Application, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2030 (%)
Y-o-Y Growth Analysis, 2022 – 2030
Segment Trends
o Disease treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Athletic performance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Academic performance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Others
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2026 – 2030
Segment Trends
7. Global Memory Enhancement Drugs Market, By Distribution Channel, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2030 (%)
Y-o-Y Growth Analysis, 2022 – 2030
Segment Trends
o Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
8. Global Memory Enhancement Drugs Market, By Region, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2030
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026-2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Pfizer Inc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
UCB S.A.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Takeda Pharmaceutical Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Shire plc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Sanochemia Pharmazeutika AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Allergan plc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
. Alkem Laboratories Ltd
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Paradigm Healthcare
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Intas Pharmaceutical Ltd.,
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Taurus Laboratories Pvt. Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
10. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們